Aquatic Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Aquatic Capital Management's RDY Position: Q2 2026 in Review
Aquatic Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 198,046 shares — an estimated $2.74M sold.
Aquatic Capital Management first reported a position in RDY in Q4 2021 and held it in 16 quarters. The position peaked at $2.74M in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Aquatic Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
- Aquatic Capital Management sold 198,046 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $2.74M.
- Aquatic Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2021 and held it in 16 quarters.
- Aquatic Capital Management's Dr. Reddy's Laboratories position peaked at $2.74M in Q1 2026.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.